Adjuvant Treatment after Surgery in Stage IIIA Endometrial Adenocarcinoma
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Yoon, Mee Sun | - |
dc.contributor.author | Huh, Seung Jae | - |
dc.contributor.author | Kim, Hak Jae | - |
dc.contributor.author | Kim, Young Seok | - |
dc.contributor.author | Kim, Yong Bae | - |
dc.contributor.author | Kim, Joo-Young | - |
dc.contributor.author | Lee, Jong-Hoon | - |
dc.contributor.author | Kim, Hun Jung | - |
dc.contributor.author | Cha, Jihye | - |
dc.contributor.author | Kim, Jin Hee | - |
dc.contributor.author | Kim, Juree | - |
dc.contributor.author | Yoon, Won Sup | - |
dc.contributor.author | Choi, Jin Hwa | - |
dc.contributor.author | Chun, Mison | - |
dc.contributor.author | Choi, Youngmin | - |
dc.contributor.author | Lee, Kang Kyoo | - |
dc.contributor.author | Kim, Myungsoo | - |
dc.contributor.author | Jeong, Jae-Uk | - |
dc.contributor.author | Chang, Sei Kyung | - |
dc.contributor.author | Park, Won | - |
dc.date.accessioned | 2021-09-03T22:11:24Z | - |
dc.date.available | 2021-09-03T22:11:24Z | - |
dc.date.created | 2021-06-18 | - |
dc.date.issued | 2016-07 | - |
dc.identifier.issn | 1598-2998 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/88112 | - |
dc.description.abstract | Purpose We evaluated the role of adjuvant therapy in stage IIIA endometrioid adenocarcinoma patients who underwent surgery followed by radiotherapy (RT) alone or chemoradiotherapy (CTRT) according to risk group. Materials and Methods A multicenter retrospective study was conducted including patients with surgical stage IIIA endometrial cancer treated by radical surgery and adjuvant RT or CTRT. Disease-free survival (DFS) and overall survival (OS) were analyzed. Results Ninety-three patients with stage IIIA disease were identified. Nineteen patients (20.4%) experienced recurrence, mostly distant metastasis (17.2%). Combined CTRT did not affect DFS (74.1% vs. 82.4%, p=0.130) or OS (96.3% vs. 91.9%, p=0.262) in stage IIIA disease compared with RT alone. Patients with age >= 60 years, grade G2/3, and lymphovascular space involvement had a significantly worse DFS and those variables were defined as risk factors. The high-risk group showed a significant reduction in 5-year DFS (>= 2 risk factors) (49.0% vs. 88.0%, p < 0.001) compared with the low-risk group (< 2). Multivariate analysis confirmed that more than one risk factor was the only predictor of worse DFS (hazard ratio, 5.45; 95% confidence interval, 2.12 to 13.98; p < 0.001). Of patients with no risk factors, a subset treated with RT alone showed an excellent 5-year DFS and OS (93.8% and 100%, respectively). Conclusion We identified a low-risk subset of stage IIIA endometrioid adenocarcinoma patients who might be reasonable candidates for adjuvant RT alone. Further randomized studies are needed to determine which subset might benefit from combined CTRT. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | KOREAN CANCER ASSOCIATION | - |
dc.subject | ADNEXAL INVOLVEMENT | - |
dc.subject | PROGNOSTIC-FACTORS | - |
dc.subject | CANCER | - |
dc.subject | CARCINOMA | - |
dc.subject | SURVIVAL | - |
dc.subject | CHEMOTHERAPY | - |
dc.subject | RADIOTHERAPY | - |
dc.subject | THERAPY | - |
dc.subject | SYSTEM | - |
dc.title | Adjuvant Treatment after Surgery in Stage IIIA Endometrial Adenocarcinoma | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Yoon, Won Sup | - |
dc.identifier.doi | 10.4143/crt.2015.356 | - |
dc.identifier.scopusid | 2-s2.0-84981313685 | - |
dc.identifier.wosid | 000380496900023 | - |
dc.identifier.bibliographicCitation | CANCER RESEARCH AND TREATMENT, v.48, no.3, pp.1074 - 1083 | - |
dc.relation.isPartOf | CANCER RESEARCH AND TREATMENT | - |
dc.citation.title | CANCER RESEARCH AND TREATMENT | - |
dc.citation.volume | 48 | - |
dc.citation.number | 3 | - |
dc.citation.startPage | 1074 | - |
dc.citation.endPage | 1083 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.identifier.kciid | ART002127480 | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.relation.journalResearchArea | Oncology | - |
dc.relation.journalWebOfScienceCategory | Oncology | - |
dc.subject.keywordPlus | ADNEXAL INVOLVEMENT | - |
dc.subject.keywordPlus | PROGNOSTIC-FACTORS | - |
dc.subject.keywordPlus | CANCER | - |
dc.subject.keywordPlus | CARCINOMA | - |
dc.subject.keywordPlus | SURVIVAL | - |
dc.subject.keywordPlus | CHEMOTHERAPY | - |
dc.subject.keywordPlus | RADIOTHERAPY | - |
dc.subject.keywordPlus | THERAPY | - |
dc.subject.keywordPlus | SYSTEM | - |
dc.subject.keywordAuthor | Endometrial neoplasms | - |
dc.subject.keywordAuthor | Adjuvant radiotherapy | - |
dc.subject.keywordAuthor | Adjuvant chemoradiotherapy | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.